4.49 USD
↘ 10.30 (69.80%)LIVE (AS OF 09:39 AM EDT)
EyePoint, Inc. Common Stock
EYPTNASDAQ • USD
Market: OPEN
EyePoint, Inc. Common Stock (EYPT) is currently trading at $4.49. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Strong Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, EYPT is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 14, 2026.
Open?$15.00
High?$15.30
Low?$3.79
Prev. Close?$14.75
Volume?10.4M
Avg. Volume?1.7M
VWAP?$4.65
Rel. Volume?6.17x
Bid / Ask
Bid?$4.44 × 100
Ask?$4.47 × 100
Spread?$0.03
Midpoint?$4.46
Valuation & Ratios
Market Cap?1.3B
Shares Out?86.2M
Float?81.1M
Float %?96.7%
P/E Ratio?N/A
P/B Ratio?7.64
EPS?-$3.56
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
Employees
214
Market Cap
1.3B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
Listed
2005-01-27
Address
480 PLEASANT STREET
WATERTOWN, MA 02472
Phone: 617-926-5000
WATERTOWN, MA 02472
Phone: 617-926-5000
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookStrong Sell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?7
Momentum?10
Short Sent.?34
Piotroski F-Score?1/9Weak
Altman Z-Score?0.67Distress
Confidence?71%Moderate
Short InterestSqueeze Risk
Short % of Float?22.21%Squeeze Risk
Short Interest?18.0M
Days to Cover?12.4
Free Float81.1M
Avg Daily Volume1.5M
Settlement Date2026-07-31
Financial Health
Current Ratio?4.50Strong
Quick Ratio?4.46Strong
Cash Ratio?2.63Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?7.64FAIR▾
Peers100
S&P24
P/S?455.94HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.7CHEAP▾
S&P97
EV/Sales?416.34HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-184.4%WEAK▾
S&P3
ROA?-134.5%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-271279000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day